SEC Form 4 · accession 0001613377-18-000034
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne S Springate
Officer — Sr. VP of Operations
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 9:42 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2018 | A | 2,500 | $0.00 | A | 67,273 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019.